Gary W. Williams

发表

MX2 Processor Module: Twice the Processors in Half the Volume

Christian L. Belady, Shaun L. Harris, Gary W. Williams, 2005 .

A Genome Sequencing Program for Novel Undiagnosed Diseases

Erick R Scott, Ali Torkamani, Eric J Topol, 2015, Genetics in Medicine.

Increased autophagy in CD4+ T cells of rheumatoid arthritis patients results in T‐cell hyperactivation and apoptosis resistance

Gary W. Williams, R. Spreafico, M. Lotz, 2016, European journal of immunology.

Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: synthesis and biological activity.

Gary W. Williams, N. Sharif, M. Mclaughlin, 2009, Bioorganic & medicinal chemistry.

Molecular mechanisms of autophagic memory in pathogenic T cells in human arthritis.

Gary W. Williams, M. Lotz, S. Saidin, 2018, Journal of autoimmunity.

Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.

Gary W. Williams, J. Crider, N. Sharif, 2003, Investigative ophthalmology & visual science.

An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors

Gary W. Williams, G. Williams, 2005, Current pain and headache reports.

AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk.

Gary W. Williams, W. Roberts, V. Strand, 2010, The American journal of cardiology.

Vitamin A Homeostasis in the Diabetic Rat.

Gary W. Williams, B. Griffin, A. Tsin, 1993, Journal of clinical biochemistry and nutrition.

AL-12182, a novel 11-oxa prostaglandin analog with topical ocular hypotensive activity in the monkey.

Gary W. Williams, N. Sharif, P. Klimko, 2004, Bioorganic & medicinal chemistry letters.

Treatment of Osteoarthritis with a Once‐Daily Dosing Regimen of Celecoxib: A Randomized, Controlled Trial

Gary W. Williams, E. Ruderman, R. Hubbard, 2000, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

15-Fluoro prostaglandin FP agonists: a new class of topical ocular hypotensives.

Gary W. Williams, N. Sharif, P. Klimko, 2004, Bioorganic & medicinal chemistry.

Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activity.

Gary W. Williams, N. Sharif, P. Klimko, 2007, Bioorganic & medicinal chemistry letters.

3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agents.

Gary W. Williams, J. Crider, N. Sharif, 2002, Bioorganic & medicinal chemistry.

Ocular hypotensive DP-class prostaglandin receptor affinities determined by quantitative autoradiography on human eye sections.

Gary W. Williams, N. Sharif, T. Davis, 2005, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.

Gary W. Williams, J. Crider, N. Sharif, 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.